DashboardPortfoliosWatchlistCommunityDiscoverScreener
  • Community
  • /
  • Switzerland
  • /
  • Pharmaceuticals & Biotech
Author Program NEWCreate Narrative
TECN logo

Tecan Group AG Stock Price

SWX:TECN Community·CHF 2.4b Market Cap
  • 3 Narratives written by author
  • 0 Comments on narratives written by author
  • 14 Fair Values set on narratives written by author
Author Program NEWCreate Narrative

TECN Share Price Performance

CHF 0
-154.70 (-100.00%)
​
CHF 184.10
Fair Value
CHF 0
-154.70 (-100.00%)
​
Price CHF 0
Thu, 3 Sep 26
Fair ValueCHF 184.10
Share Pricen/a

TECN Community Narratives

AN
AnalystConsensusTarget
AnalystConsensusTarget's
Fair Value
·
Fair Value CHF 184.1 8.1% overvalued intrinsic discount

TECN: Resilient Demand And Share Repurchase Program Will Drive Shareholder Value

0users have liked this narrative
0users have commented on this narrative
7users have followed this narrative
AN
AnalystHighTarget
AnalystHighTarget's
Fair Value
·
Fair Value CHF 220 9.5% undervalued intrinsic discount

Lab Automation And Personalized Medicine Will Unlock Secular Opportunities

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AN
AnalystLowTarget
AnalystLowTarget's
Fair Value
·
Fair Value CHF 160 24.4% overvalued intrinsic discount

Tariffs And Disruptions Will Crush Margins While Cuts Will Help

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
TECN logo
Tecan Group
8.1% overvalued intrinsic discount

TECN: Resilient Demand And Share Repurchase Program Will Drive Shareholder Value

View narrative
AN
AnalystConsensusTarget
AnalystConsensusTarget
Updated 3 Sep
Read Narrative
TECN logo
Tecan Group
24.4% overvalued intrinsic discount

Tariffs And Disruptions Will Crush Margins While Cuts Will Help

View narrative
AN
AnalystLowTarget
AnalystLowTarget
Updated 18 Aug
Read Narrative
TECN logo
Tecan Group
9.5% undervalued intrinsic discount

Lab Automation And Personalized Medicine Will Unlock Secular Opportunities

View narrative
AN
AnalystHighTarget
AnalystHighTarget
Updated 4 Aug
Read Narrative

Trending Discussion

No trending discussion available.

Recently Updated Narratives

AN
AnalystConsensusTarget
TECN logo

TECN: Margin Execution And 2028 Goals Will Shape Fairly Valued Outlook

Fair Value: CHF 184.1 8.1% overvalued intrinsic discount
7 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
AnalystLowTarget
TECN logo

TECN: Margin Execution Concerns Will Constrain Upside Despite Raised Expectations

Fair Value: CHF 160 24.4% overvalued intrinsic discount
0 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
AnalystHighTarget
TECN logo

TECN: Margin Upside And India Expansion Will Support Future Earnings Re Rating

Fair Value: CHF 220 9.5% undervalued intrinsic discount
0 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative

Snowflake Analysis

Undervalued with excellent balance sheet.

1 Risk
3 Rewards
View Full Analysis

Tecan Group AG Key Details

CHF 870.5m

Revenue

CHF 574.0m

Cost of Revenue

CHF 296.5m

Gross Profit

CHF 412.8m

Other Expenses

-CHF 116.3m

Earnings

Last Reported Earnings
Jun 30, 2026
Next Reporting Earnings
Nov 05, 2026
-9.44
34.06%
-13.36%
13.6%
View Full Analysis

About TECN

Founded
1980
Employees
3000
CEO
Monica Manotas
WebsiteView website
www.tecan.com

Tecan Group AG provides laboratory instruments and solutions in biopharmaceuticals, forensics, and clinical diagnostics in Europe, North America, Asia, and internationally. It operates in two segments: Life Sciences Business and Partnering Business. The company offers liquid handling and automation, microplate readers and washers, software, consumables, sequencing reagents, immunoassays and antibodies, and Tecan Labwerx, an end-to-end automation solution. It also provides PARAMIT, a contract design and manufacturing service. Tecan Group AG has a strategic collaboration with NVIDIA Corporation to develop AI-enabled platform for data-driven laboratories to help discoveries and lab productivity. The company was founded in 1980 and is headquartered in Männedorf, Switzerland.

Recent TECN News & Updates

User avatar
Narrative Update • Sep 03

TECN: Margin Execution And 2028 Goals Will Shape Fairly Valued Outlook

Tecan Group's analyst price target has been revised higher, with the updated fair value estimate moving from CHF 175.48 to CHF 184.10 as analysts factor in recent target increases from UBS, Deutsche Bank and Morgan Stanley, along with a reduced future P/E assumption. Analyst Commentary Recent research on Tecan Group shows a mix of optimism on execution and caution on valuation, as reflected in a series of target price changes and rating moves over recent months.
User avatar
Narrative Update • Aug 18

TECN: Margin Execution Concerns Will Constrain Upside Despite Raised Expectations

Analysts have raised the fair value estimate for Tecan Group from CHF 142.0 to CHF 160.0, reflecting updated assumptions on revenue growth, profit margins and valuation in the context of recent price target increases from major banks. Analyst Commentary Recent research on Tecan Group shows a mix of optimism and caution.

Recent updates

No updates

Tecan Group AG Competitors

BANB logo

Bachem Holding

Symbol: SWX:BANB
Market cap: CHF 5.9b
DESN logo

Dottikon ES Holding

Symbol: SWX:DESN
Market cap: CHF 3.6b
SFZN logo

Siegfried Holding

Symbol: SWX:SFZN
Market cap: CHF 3.1b
View more competitors

Make Better Investing Decisions Anywhere

Scan to download
Open AppStoreOpen Google Play
Chrome Web Store
Level 5, 320 Pitt Street, Sydney
Financial Data provided by S&P Global Market Intelligence LLC, analysis provided by Simply Wall Street Pty Ltd. Copyright © 2026, S&P Global Market Intelligence LLC. All rights reserved.
View Data Sources
Markets
  • US: NYSE & NASDAQ
  • UK: FTSE
  • Australia: ASX
  • India: NIFTY
  • Canada: TSX
  • South Africa: JSE
  • Japan: NIKKEI
  • South Korea: KOSPI
  • Germany: DAX
Investing Ideas
  • Undervalued Companies
  • Dividend Powerhouses
  • Insider Buying
  • Nuclear Energy
  • Autonomous Vehicles
  • Artificial Intelligence
  • Crypto and Blockchain
  • Cybersecurity
  • More ideas
Stock Communities
  • AstraZeneca
  • HSBC Holdings
  • Shell
  • Unilever
  • Diageo
  • Rio Tinto Group
  • RELX
  • BP
  • Barclays
Features & Tools
  • Portfolio Tracker
  • Stock Screener & Alerts
  • Narratives & Fair Values
  • Dividend Calculator
News & Discovery
  • Latest Stock News
  • Global Market Insights
  • The Foxhole
  • Investing Ideas
  • Community Narratives
  • What's New
Simply Wall St
  • Plans & Pricing
  • Advertising
  • About Us
  • Contact Us
  • Careers
  • Help Center
  • Learn Stock Investing
  • Affiliate Program
  • Business & Enterprise
  • Charlie AI
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
© 2026 Simply Wall Street Pty Ltd, US Design Patent #29/544/281, Community and European Design Registration #2845206
  • Terms and Conditions
  • Privacy Policy
  • AI Terms
  • Financial Services Guide